Literature DB >> 2863124

Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

J Webster.   

Abstract

Indomethacin attenuates the antihypertensive effect of both thiazide diuretics and beta-adrenoceptor blocking drugs. The mechanisms of these interactions are poorly understood but sodium and water retention, suppression of plasma renin activity, alterations in adrenoceptor sensitivity and impaired synthesis of vasodilator prostaglandins may all contribute to this effect. Other non-steroidal anti-inflammatory drugs (NSAIDs) may share this property of indomethacin but sulindac, which is a selective inhibitor of extrarenal prostaglandin synthesis, appears not to. This may have important clinical and theoretical implications. Clinicians must beware of this potential interaction in any patient receiving treatment for hypertension. NSAIDs may also inhibit the natriuretic response to diuretics with resultant adverse effects in patients with heart failure and other forms of oedema. NSAIDs may also have adverse nephrotoxic effects which may be exacerbated by diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863124     DOI: 10.2165/00003495-198530010-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  58 in total

Review 1.  The role of alpha- and beta-presynaptic receptors in the regulation of noradrenaline release elicited by nerve stimulation.

Authors:  S Z Langer
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

2.  Antagonistic effect of non-steroidal anti-inflammatory drugs on frusemide-induced diuresis in cardiac failure.

Authors:  A C Laiwah; R A Mactier
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

3.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.

Authors:  J Watkins; E C Abbott; C N Hensby; J Webster; C T Dollery
Journal:  Br Med J       Date:  1980-09-13

4.  Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.

Authors:  J W Hollifield; K Sherman; R V Zwagg; D G Shand
Journal:  N Engl J Med       Date:  1976-07-08       Impact factor: 91.245

5.  Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man.

Authors:  J Nowak; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1978-04

6.  Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin.

Authors:  G Ciabattoni; G A Cinotti; A Pierucci; B M Simonetti; M Manzi; F Pugliese; P Barsotti; G Pecci; F Taggi; C Patrono
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

7.  Do diuretics have antihypertensive properties independent of natriuresis?

Authors:  W M Bennett; W J McDonald; E Kuehnel; M N Hartnett; G A Porter
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

8.  Flurbiprofen interaction with single doses of atenolol and propranolol.

Authors:  J Webster; J C Petrie; I McLean; G M Hawksworth
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

9.  Hyperkalemia associated with indomethacin.

Authors:  R C Goldszer; E L Coodley; M J Rosner; W M Simons; A B Schwartz
Journal:  Arch Intern Med       Date:  1981-05

10.  Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects.

Authors:  L Favre; P Glasson; M B Vallotton
Journal:  Ann Intern Med       Date:  1982-03       Impact factor: 25.391

View more
  19 in total

1.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

5.  Interaction of indomethacin and sulindac with labetalol.

Authors:  M A Abate; J L Neely; R D Layne; R D'Alessandri
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

6.  Practical therapy: adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs) in therapy of hypertension and congestive heart failure.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

Review 7.  Adverse drug interactions.

Authors:  M J Brodie; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-19

Review 8.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

Review 9.  The elderly patient. A special case for diuretic therapy.

Authors:  D E Hyams
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 10.  Aspirin and related derivatives of salicylic acid.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.